Effect of Low-calorie Diet and Orange Juice on Body Weight and Metabolic Parameters of Obese Subjects (LCD-OJ-OBESE)

September 26, 2016 updated by: Thais Cesar, São Paulo State University

Low-calorie Diet Combined With Orange Juice Results in Weight Loss: Randomized Controlled Trial

This study aimed to verify if combination of a low calorie diet and orange juice consumption results in weight loss and ameliorates metabolic obesity-related biomarkers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Seventy-eight obese subjects aged 36 ± 1 years and BMI of 33 ± 3 kg were randomly divided into two parallel groups: (1) orange juice (n = 39), composed of individuals subjected to a diet low caloric diet and plus intake of 500 ml orange juice; (2) control (n = 39) composed of individuals subjected to a diet low in calories. The recruitment process began in September 2015, the intervention was carried out from October 2015 to January 2016, and the data analysis started in February 2016. The sample number took into account variances on body weight with a type I error α = 0.05 and a type II error β = 0.2 (80% power). The minimum sample size should have 36 individuals per group (n = 72), considering an approximately 15% dropout rate. Thus, the final sample size of study was constituted by 39 individuals per group (n = 78). Primary and secondary endpoints were the reduction of weight and modification of the levels of obesity-related metabolic biomarkers, respectively. Normality and homogeneity of data were tested. T-test was conducted to identify possible differences between OJ and control groups at baseline. A linear mixed-effects model was apply to determine the time effect within and between groups (post hoc), and P significance was set up ≤ 0.05. The assessment of body composition, metabolic biomarkers and food intake were analyzed over a 12-week intervention.

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 30 > BMI < 40 kg/m2

Exclusion Criteria:

  • Dieting last year,
  • Use of drugs, vitamins and dietary supplements
  • Alcohol consumption (> 20 g alcohol/d)
  • Intense physical activity (> 5 hours/week).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Orange juice
Orange juice: thirty-nine obese individuals were submitted to a low-caloric diet (500 kcal/d of energy restriction) plus 100% orange juice (500 mL/d) during 12 weeks.
Nutritionists prescribed a low-calorie diet that was estimated from total energy expenditure (TEE) for each individual minus 500 kcal per day (30% TEE). Both groups had the same diet plan based on individual weight. The dietary plan was composed of six meals/day: breakfast (fat-free milk and coffee; whole-grain bread with margarine, and an apple); snack 1 (250 mL OJ / banana and free-fat yogurt); lunch (brown rice, beans, grilled lean meat, salad, cooked vegetables); snack 2 (250 mL OJ / free-fat yogurt with oatmeal); dinner (brown rice, beans, grilled lean meat, cooked vegetables and salad); and snack 3 (salty crackers or oat cookies, tea without sugar). Body composition measurements were collected (monthly); blood samples and dietary questionnaires (every two weeks).
No Intervention: Control
Control: thirty-nine obese individuals were submitted to a low-caloric diet (500 kcal/d of energy restriction) during 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Body-weight
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Total cholesterol
Time Frame: 12 weeks
12 weeks
Body mass index (BMI)
Time Frame: 12 weeks
12 weeks
Body lean mass
Time Frame: 12 weeks
12 weeks
Body fat mass
Time Frame: 12 weeks
12 weeks
Percentage of body fat
Time Frame: 12 weeks
12 weeks
Ratio waist/hip
Time Frame: 12 weeks
12 weeks
Glucose
Time Frame: 12 weeks
12 weeks
Insulin
Time Frame: 12 weeks
12 weeks
Homeostatic Model assessment of Insulin Resistance
Time Frame: 12 weeks
12 weeks
LDL-cholesterol
Time Frame: 12 weeks
12 weeks
HDL-cholesterol
Time Frame: 12 weeks
12 weeks
Non-HDL-cholesterol
Time Frame: 12 weeks
12 weeks
Triglycerides
Time Frame: 12 weeks
12 weeks
hsCRP
Time Frame: 12 weeks
12 weeks
Alkaline phosphatase
Time Frame: 12 weeks
12 weeks
Aspartate transaminase
Time Frame: 12 weeks
12 weeks
Alanine transaminase
Time Frame: 12 weeks
12 weeks
Gamma-glutamyl transferase
Time Frame: 12 weeks
12 weeks
Antioxidant capacity (ABTS)
Time Frame: 12 weeks
12 weeks
Lipid peroxidation (TBARS)
Time Frame: 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thais B Cesar, Ph.D., Sao Paulo State University "Julio de Mesquita Filho" (UNESP)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

September 22, 2016

First Submitted That Met QC Criteria

September 23, 2016

First Posted (Estimate)

September 26, 2016

Study Record Updates

Last Update Posted (Estimate)

September 28, 2016

Last Update Submitted That Met QC Criteria

September 26, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Orange juice (500 mL/d)

3
Subscribe